Aurobindo Pharma Limited - Company & Market Research Reports

Home /
Companies /
Aurobindo Pharma Limited

Founded in 1986, Aurobindo manufactures generic pharmaceutical drugs. The company has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. Aurobindo Pharma features among the top 10 companies in India in terms of consolidated revenues. It exports to over 125 countries across the globe with more than 70% of its revenues derived out of international operations.

REFINE BY

KEYWORD

CATEGORIES

Infectious Diseases Drugs 78
Cardiovascular Drugs 72
Antibiotics 55
Generic Drugs 47
Central Nervous System Drugs 43
Respiratory Drugs 42
Pharmaceutical Intermediates 41
Immune Disorders Drugs 41
Gastrointestinal Drugs 41
Musculoskeletal Disorders Drugs 37
Oncology Drugs 35
Urological Disorders Drugs 33
Analgesics 31
Sexual and Reproductive Health Drugs 27
Animal Pharmaceuticals 26
Pharmaceuticals 26
Endocrine and Metabolic Disorders Drugs 23
Bronchitis Drugs 23
Mental Disorders Drugs 21
Lung Cancer Drugs 17
HIV/AIDS Drugs 17
Pharmaceutical Manufacturing 17
Infusions and Injectables 16
Over the Counter (OTC) Drugs 16
Anxiety Drugs 15
Vitamins and Dietary Supplements 13
Allergy and Immunology 11
Optical Disorders Drugs 10
Cough and Cold Drugs 10
Hematological Drugs 10
Dermatological Drugs 10
Drug Discovery 9
Breast Cancer Drugs 9
Liver and Kidney Disorders Drugs 9
Acne Drugs 9
Women's Health 8
Biopharmaceuticals 8
Gastroenterology 8
Alzheimer's Disease Drugs 8
Asthma Drugs 8
Immunosuppressive Drugs 8
Ovarian Cancer Drugs 7
Pancreatic Cancer Drugs 7
Drugs by Therapeutic Area 6
Diabetes Drugs 6
Prostate Cancer Drugs 6
Kidney Cancer Drugs 6
Thyroid Cancer Drugs 6
Schizophrenia Drugs 6
Pulmonary Medicine 5
Urology and Nephrology 5
Colon Cancer Drugs 5
Optical 5
Addiction Disorders Drugs 4
Healthcare Services 4
Leukemia Drugs 4
Brain Cancer Drugs 4
Bladder Cancer Drugs 4
Infectious Disease Testing 4
Enzymes 4
Mental Health 4
Skin Cancer Drugs 4
Company Reports 3
Therapeutic Area 3
Neurology 3
Cervical Cancer Drugs 3
Clinical Trials 3
Anesthetic Drugs 3
Biosimilars and Biosuperiors 3
Oncology 3
Psoriasis Drugs 3
Biotechnology 2
Liver Cancer Drugs 2
Fertility Services 2
In Vitro Diagnostics 2
Transdermal and Transmucosal Drug Delivery 2
Diagnostics 2
Drug Delivery 2
Sports Medicine and Physiotherapy 2
Surgical Devices 2
Vaccines 2
Uterine Cancer Drugs 2
Anti-Obesity Drugs 2
Pediatrics 2
Cardiology 2
Lymphoma Drugs 1
Genomics 1
Point-of-Care Diagnostics 1
Healthcare 1
Diabetes Devices 1
Inhalers and Nebulisers 1
Medical Devices 1
Respiratory Devices 1
Needles and Syringes 1
Dermatology 1
Surgical Procedures 1
Hematology 1
Nuclear Medicine and Radiopharmacology 1
Laboratory Equipment 1
Intensive Care and Emergency Medicine 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

711 Results (Page 4 of 36)
- Relevance
  Sort by

Gemifloxacin Market - Global Forecast 2025-2032

 Report
October 2025
181 Pages
Global

From

€3147EUR$3,545USD£2,744GBP

€3496EUR$3,939USD£3,048GBP

HIV Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3985EUR$4,490USD£3,475GBP

Doxepin Hydrochloride Tablets Market - Global Forecast 2025-2030

 Report
August 2025
190 Pages
Global

From

€3147EUR$3,545USD£2,744GBP

€3496EUR$3,939USD£3,048GBP

Topiramate Tablets Market - Global Forecast to 2030

 Report
August 2025
192 Pages
Global

From

€3147EUR$3,545USD£2,744GBP

€3496EUR$3,939USD£3,048GBP

Quetiapine Fumarate Tablets Market - Global Forecast 2025-2030

 Report
August 2025
183 Pages
Global

From

€3147EUR$3,545USD£2,744GBP

€3496EUR$3,939USD£3,048GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Olanzapine Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3985EUR$4,490USD£3,475GBP

Olanzapine Market by Application, Route of Administration, Distribution Channel, and Geography: Forecast to 2027

 Report
July 2023
214 Pages
Global

From

€3994EUR$4,500USD£3,483GBP

Intravenous Ibuprofen - Global Strategic Business Report

 Report
October 2025
470 Pages
Global

From

€5193EUR$5,850USD£4,527GBP

Ceftazidime Nucleus Market - Global Forecast 2025-2030

 Report
August 2025
194 Pages
Global

From

€3147EUR$3,545USD£2,744GBP

€3496EUR$3,939USD£3,048GBP

Cold Sore Treatment - Global Strategic Business Report

 Report
October 2025
469 Pages
Global

From

€5193EUR$5,850USD£4,527GBP

Belladonna Sulfadiazine Tablets Market - Global Forecast 2025-2030

 Report
August 2025
186 Pages
Global

From

€3147EUR$3,545USD£2,744GBP

€3496EUR$3,939USD£3,048GBP

Global Healthcare CMO Market (by Type, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)

 Report
October 2023
140 Pages
Global

From

€3994EUR$4,500USD£3,483GBP

Acetaminophen-Opioid Combination Market - Global Forecast 2025-2030

 Report
August 2025
196 Pages
Global

From

€3147EUR$3,545USD£2,744GBP

€3496EUR$3,939USD£3,048GBP

Naproxen Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
January 2024
100 Pages
Global

From

€3500EUR$4,224USD£3,158GBP

Gonorrhea Therapeutics Market 2025-2029

 Report
July 2025
220 Pages
Global

From

€2219EUR$2,500USD£1,935GBP

Chemotherapy-Induced Neutropenia Treatment - Global Strategic Business Report

 Report
October 2025
381 Pages
Global

From

€5193EUR$5,850USD£4,527GBP

Brimonidine Tartrate Eye Drops Market - Global Forecast 2025-2030

 Report
August 2025
184 Pages
Global

From

€3147EUR$3,545USD£2,744GBP

€3496EUR$3,939USD£3,048GBP

Spironolactone Drugs Market - Global Forecast 2025-2030

 Report
August 2025
190 Pages
Global

From

€3147EUR$3,545USD£2,744GBP

€3496EUR$3,939USD£3,048GBP

Risperidone Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
126 Pages
Global

From

€3500EUR$4,224USD£3,158GBP

Genital Herpes Treatment Market - Global Outlook and Forecast 2022-2027

 Report
July 2022
298 Pages
Global

From

€3107EUR$3,500USD£2,709GBP

711 Results (Page 4 of 36)
- 1
- 2
- 3
- 4
- 5
- 6

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.